Viatris (VTRS) Enterprise Value (2019 - 2026)
Viatris (VTRS) posted Enterprise Value of $17.4 billion for Q2 2026, up 24.58% on a QoQ basis from $13.9 billion in Q1 2026, and up 76.27% year-over-year from $9.8 billion in Q2 2025.
Analysis
Viatris (VTRS) Enterprise Value (2019 - 2026) Analysis & Trends
Viatris has reported Enterprise Value for 8 years, with the latest figure at $17.4 billion in Q2 2026.
- On a quarterly basis, Enterprise Value rose 76.27% year-over-year to $17.4 billion in Q2 2026; TTM through Jun 2026 was $17.4 billion, a 76.27% increase from a year earlier, with the FY2025 full-year figure at $13.0 billion, down 7.88% from the prior year.
- Enterprise Value was $17.4 billion for Q2 2026 at Viatris, up from $13.9 billion in the prior quarter.
- The five-year high for Enterprise Value was $17.4 billion in Q2 2026, with the low at $9.5 billion in Q1 2025.
- Average Enterprise Value over 5 years is $12.0 billion, with a median of $11.9 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value tumbled 38.04% in 2022, then soared 76.27% in 2026.
- Over 5 years, Enterprise Value stood at $12.1 billion in 2022, then fell by 1.56% to $11.9 billion in 2023, then rose by 19.01% to $14.1 billion in 2024, then dropped by 7.88% to $13.0 billion in 2025, then jumped by 33.36% to $17.4 billion in 2026.
- The last three Enterprise Value figures came in at $17.4 billion (Q2 2026), $13.9 billion (Q1 2026), and $13.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.35 Bn |
| Mar 31, 2026 | 13.93 Bn |
| Dec 31, 2025 | 13.01 Bn |
| Sep 30, 2025 | 10.43 Bn |
| Jun 30, 2025 | 9.84 Bn |
| Mar 31, 2025 | 9.47 Bn |
| Dec 31, 2024 | 14.13 Bn |
| Sep 30, 2024 | 11.98 Bn |
| Jun 30, 2024 | 11.77 Bn |
| Mar 31, 2024 | 13.20 Bn |
| Dec 31, 2023 | 11.87 Bn |
| Sep 30, 2023 | 10.52 Bn |
| Jun 30, 2023 | 11.34 Bn |
| Mar 31, 2023 | 11.03 Bn |
| Dec 31, 2022 | 12.06 Bn |
| Sep 30, 2022 | 9.69 Bn |
| Jun 30, 2022 | 12.03 Bn |
| Mar 31, 2022 | 12.44 Bn |
| Dec 31, 2021 | 15.66 Bn |
| Sep 30, 2021 | 15.63 Bn |